Cold, Cough, and Sore Throat Remedies Market Report 2026

The cold, cough, and sore throat remedies market size has grown strongly in recent years. It will grow from $47.85 billion in 2025 to $50.65 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to high incidence of respiratory infections, widespread OTC availability, strong seasonal illness patterns, established retail pharmacy networks, traditional use of cough and throat remedies.

The cold, cough, and sore throat remedies market size is expected to see strong growth in the next few years. It will grow to $63.53 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing urban air pollution, rising self-medication practices, growing geriatric population, expansion of e-commerce pharmacies, demand for fast-acting symptom relief. Major trends in the forecast period include rising demand for multi-symptom relief products, growing preference for herbal and natural remedies, increased consumption of lozenges and throat sprays, expansion of over-the-counter treatment options, higher adoption of combination formulations.

The increasing prevalence of respiratory infections is expected to drive the growth of the cold, cough, and sore throat remedies market in the coming years. Respiratory infections are illnesses caused by viruses, bacteria, or other pathogens that impact the respiratory system, including the nose, throat, airways, and lungs, resulting in symptoms such as coughing, congestion, sore throat, and difficulty breathing. The incidence of respiratory infections is rising due to increasing air pollution, which weakens the respiratory system and makes individuals more vulnerable to infections. Cold, cough, and sore throat remedies aid in managing respiratory infections by soothing irritation, alleviating congestion, and supporting the body's natural defenses against pathogens. For example, in June 2025, according to the Office for Health Improvement & Disparities, a UK government agency, England recorded 854,922 emergency respiratory-related hospital admissions in the year ending 2024, equivalent to a rate of 1,428 per 100,000 people, representing a 7% increase from the previous year. Despite this rise, rates remain below pre-pandemic levels. Consequently, the growing prevalence of respiratory infections is fueling the expansion of the cold, cough, and sore throat remedies market.

Major companies in the cold, cough, and sore throat remedies market are concentrating on creating innovative products, such as clean cough and cold medicines, to address the increasing demand for safer, chemical-free alternatives while improving product efficacy and consumer confidence. Clean cough and cold medicines are formulated without artificial dyes, sweeteners, preservatives, or common allergens, utilizing natural or organic ingredients to provide safer symptom relief. For example, in September 2023, Genexa Inc., a US-based healthcare company, introduced new clean cough and cold medicines for children, including Kids’ Multi-Symptom Cold And Flu and Kids’ Daytime + Nighttime Cough Relief Value Pack. These products are free from artificial dyes, sweeteners, parabens, and common allergens, and use organic agave syrup as a natural substitute for artificial fillers. They deliver effective relief with the same active ingredients as conventional brands but in a clean, non-toxic formulation. Sold at major retailers such as Walmart, Walgreens, and Amazon, these products cater to parents looking for safer and more natural OTC medicine options for their children.

In October 2024, Recordati SpA, an Italy-based pharmaceutical company, acquired the rights to Enjaymo, a therapy for cold agglutinin disease (CAD), from Sanofi for $825 million. Through this acquisition, Recordati intends to strengthen its rare disease portfolio, broaden its presence in hematology and immunology, and boost its global market position by capitalizing on Enjaymo’s potential in treating cold agglutinin disease (CAD). Sanofi S.A. is a France-based company that produces remedies for cold, cough, and sore throat.

Major companies operating in the cold, cough, and sore throat remedies market are Procter & Gamble Co., Johnson & Johnson, Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Health Ltd., Prestige Brands Holdings Inc., Marksans Pharma Ltd., Weefsel Pharma Pvt. Ltd., Sunwin Healthcare Pvt. Ltd., AdvaCare Pharma USA, Genexa Inc., Himalaya Wellness Company, Benylin, Medella Softgel Private Limited.

North America was the largest region in the cold, cough, and sore throat remedies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cold, cough, and sore throat remedies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cold, cough, and sore throat remedies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the cold, cough, and sore throat remedies market by increasing the cost of imported active pharmaceutical ingredients, excipients, and herbal extracts used in symptomatic treatments. These impacts have been most pronounced in combination drug and lozenge segments, particularly in north america and europe where API and ingredient sourcing is globally diversified. Asia-pacific manufacturers have faced supply chain disruptions and pricing pressure due to import dependencies. However, tariffs have encouraged domestic formulation manufacturing and local sourcing of herbal inputs, supporting supply continuity.

The cold, cough, and sore throat remedies market research report is one of a series of new reports that provides cold, cough, and sore throat remedies market statistics, including cold, cough, and sore throat remedies industry global market size, regional shares, competitors with a cold, cough, and sore throat remedies market share, detailed cold, cough, and sore throat remedies market segments, market trends and opportunities, and any further data you may need to thrive in the cold, cough, and sore throat remedies industry. This cold, cough, and sore throat remedies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medications, natural supplements, and treatments aimed at alleviating symptoms of respiratory infections, such as congestion, coughing, and throat irritation, help relieve cold, cough, and sore throat. These include lozenges and herbal formulations that provide soothing relief and support quicker recovery.

The primary drugs used for treating cold, cough, and sore throat include antihistamines, expectorants, bronchodilators, decongestants, antibiotics, and other medications. Antihistamines are drugs that inhibit histamine, a chemical in the body responsible for allergic responses such as sneezing, itching, and a runny nose. The different forms available are oral syrups, tablets and pills, nasal drops, lozenges, and others. These drugs are used for various purposes, including relieving cold symptoms, suppressing cough, alleviating throat pain, providing allergy relief, reducing sinus pressure, and supporting general immunity, and they are distributed through multiple channels such as hospital pharmacies, retail pharmacies, drug stores, supermarkets and hypermarkets, as well as e-commerce and online pharmacies.

The cold, cough, and sore throat remedies market consists of sales of cough syrups, throat sprays, herbal teas, menthol rubs, nasal sprays, pain relievers, and immunity-boosting supplements. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.